{"name":"Icure Pharmaceutical Inc.","slug":"icure-pharmaceutical-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"aricept Tab","genericName":"aricept Tab","slug":"aricept-tab","indication":"Alzheimer's disease","status":"phase_3"}]}],"pipeline":[{"name":"aricept Tab","genericName":"aricept Tab","slug":"aricept-tab","phase":"phase_3","mechanism":"Aricept (donepezil) is a cholinesterase inhibitor that works by increasing the concentration of acetylcholine in the brain, which helps to improve cognitive function in patients with Alzheimer's disease.","indications":["Alzheimer's disease","Vascular dementia"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQZDBHazNvRjUtNFh5cWlvY0M5RXV5VVZwenJKUUpHdjJ0cHRoallnRnNJNXUxWHg2OWFfZjJtOW12U0ZNeVdfY19SVVphczNOWXU5ZVZWUE1lb0F5cU9jVnVFT0VRZlVfQ2lWQWxGQkRrdjVLRENwVlUtTWNEN0xoQ3NqMG9SM1kzbTJxMjdMVFlmRkVia1QwYmlKRmdDQ19pQU90N2xzaTk1NzA?oc=5","date":"2025-11-03","type":"pipeline","source":"TechStock²","summary":"CURE Pharmaceutical (CURR) Stock Skyrockets Amid Wellness Pivot – What’s Next for Investors? - TechStock²","headline":"CURE Pharmaceutical (CURR) Stock Skyrockets Amid Wellness Pivot – What’s Next for Investors? - TechStock²","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFAwRkVGbjRtWE9ZcEx4aXhuaHBlQjVETjVSY3JmeGlEdWhGbWVQV2J0YzN3M01fTDhaZnk5ZzRITXhEbGQyUDlZRjRlRE1aYTI4aTFGNFhiS2RfdC1mSXB1N3dSeHlXM3NHaDFkOENR0gFyQVVfeXFMT2RlQjhycVplazlwSk9uVkZZX0phemtNQUdYZkZGSUVieWpFbnBoZS1rd1JHamNtLWVyS3JXYTM3d3Fydm5MQzIzSUFGMkhUZVNtVUxibVVNcnUzNmlZQjFiNmoyWjRTYmRucWt4YXBWalZn?oc=5","date":"2025-08-06","type":"pipeline","source":"koreabiomed.com","summary":"Icure Pharmaceutical chairman indicted for $12 mil. embezzlement; stock trading halted - koreabiomed.com","headline":"Icure Pharmaceutical chairman indicted for $12 mil. embezzlement; stock trading halted","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1aOGdRQlBxR0dXUXNtdy1FbVpZandLRWU3UXlKVHVGLTBYY3lSekVpTDZya3N4NDFwVV91YzVqZHZRY0VxdHZTV25TeXg3WGhjemR0Q2NFRkNjbHNXUWhiaG5xQl9wV3MxMWJBb2x3?oc=5","date":"2023-12-19","type":"regulatory","source":"KED Global","summary":"Icure wins $2.85 mn lidocaine cataplasm order from Guatemala - KED Global","headline":"Icure wins $2.85 mn lidocaine cataplasm order from Guatemala","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE41YWpjVGVMSnUtNm9hU1FwNnZMUTdMVDY4ekVrZWNuckYxX0xfcmFEN3pYQU83cWprZTZTREV2UWZIVVp1NzN2bzF3OVZTMHZKRUZORjg5Xy03S3hQUFF1a3ptM1huTUMwcTRvcWF30gFyQVVfeXFMTmcteFBzN3ZTUFVTSnlGbWl5WTJMdE5KODZTNWl1QzhWOGM1dk1qUk5yRGpGTjFsZmJCNm5ILXJrZGZmVktnazNFNFFmcUttejdpaDd4NGh5UGplOTlMbjRodTR2MWVkUjJqdmpveW1KclZB?oc=5","date":"2023-02-27","type":"pipeline","source":"koreabiomed.com","summary":"Menarini to supply Icure Pharmaceutical's dementia patch to Taiwan, Thailand - koreabiomed.com","headline":"Menarini to supply Icure Pharmaceutical's dementia patch to Taiwan, Thailand","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOaUNpTy02T3dCU3NrZlpsYTc0YjBCaDVOTFJrYmhYcXhuaGo5VXd0U2c0WFAtaExwSVg0ZFhyMlFyU2JOcldGbHd6dHVoMjlzZ1BuRndyMXFpSllpNktpSmpzcXdxc2p0azVfcTVuNkhNX0xWcFRBa2xPMkQ1YzVsU2FrczdJSEJrTWVSaGpueE5vQkVkdUEyZjRGZXhFUE1JSWs1VlV0YXpOLWtscEF5dEo1eVI3N0IyM0tPUw?oc=5","date":"2021-11-17","type":"regulatory","source":"BioSpectrum Asia","summary":"Korea approves 'donepezil patch' for treating Alzheimer's-type dementia - BioSpectrum Asia","headline":"Korea approves 'donepezil patch' for treating Alzheimer's-type dementia","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1GOWVYYUNFMTA5eFlsWDlaRUdKZlRnNHVsMEtyN0N3aHBUa25na3VWVWZqQzM0Njg5QjY5WXZnUUJtNmttdlkyWlN5ZHZKbWtwcElUYXlNYi1rMzBVUFBrVjZMZGlxVkpYMlNndTdR0gFyQVVfeXFMUFVjeXpwd2hISDFoZXhVZUE3bUlxSHdsOF9yU1RNOTdWNEQtb2oxVFY3T2FmbklKWjctSlZEZEFQNVhaQzhoX3VfUW5tYnZWS0ZXYXQxamE5SDdpV3BpNWNGTnk0RVFJZncyVmZtVVlBZ1ln?oc=5","date":"2021-11-08","type":"pipeline","source":"koreabiomed.com","summary":"Icure's patch-type Alzheimer's treatment draws interest - koreabiomed.com","headline":"Icure's patch-type Alzheimer's treatment draws interest","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiSEFVX3lxTE1PMlg0aHJTZWFKQl90eURCeW1zUF8yYTNDbmxYa1NSQTQxd1JWc2FpUmcydWlwc3FQOVNYVXRKTVAzc2tzZ210UA?oc=5","date":"2020-12-02","type":"deal","source":"StockInvest.us","summary":"Cure Pharmaceutical Holding Stock Price Forecast. Should You Buy CURR? - StockInvest.us","headline":"Cure Pharmaceutical Holding Stock Price Forecast. Should You Buy CURR?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxPMTdCcEdENDVBRjNSQW45RXRxUUpWd0kzX0RHZjNKZ1pOazMzQ1Z1azRPZU1sdkRGRThlZ09fMFFkQ3ZFQktHSjdneWRVYTM0aEZmVmhrLUtiWXowVXFlMTEzUmxjS2NFUXM4RXU5QWtMX2RlbW5WalpvM2VoV2dYSjI4UXB3SFAxRmtoamVOUXJ0OVgxRk9QUlpzUzVCTHhLVVNLUmVWS2lNYldJS00wRzk1N1dzSDhHeVZad21nTk9rMkFvelBQSUhxMmhLSDhuRGNKV21sNlRseUpfOUsyLUJjazN6MkI5bXZTaWZXSjhBOFBYdGRiUUFLTFNHSVRUYWJaREE0UWR1Rjk2M193?oc=5","date":"2020-10-29","type":"pipeline","source":"Business Wire","summary":"CURE Pharmaceutical’s® Wholly Owned Subsidiary SeraLabs® Introduces Nutri-Strips™, a Revolutionary Oral Thin Film Strip Technology - Business Wire","headline":"CURE Pharmaceutical’s® Wholly Owned Subsidiary SeraLabs® Introduces Nutri-Strips™, a Revolutionary Oral Thin Film Strip ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAJBVV95cUxOSTl0bUVERE1iWk04cmEwSUR2ZnV4ajRyWUNCRU1EQW9LUEdicmlhRlBvOEp2dkh4VUxtWTdBLWhzclEydERuQzdHSXRDaTRKdkx4MXllNXVZMURPeThLcWUwalZqNEpkWjhIdFdOZnZfdEdQRldZQTlJeXFiczNsNFg2ZDdkOGh3SUJEbThfUlk1Mkdsbl9tQnluN3BSTVd0aVFpdEVodjNvVVhMV1F0NnVUbmxNQUxuSzVDekwzVUhEeUxmNGJQWTJpdXU2NklFMmF1dnRpbXIxbWVmMDR2NmlEdktLVXFPUEF0clFfVVc5SUtUZmp3U3hKeE9MbmdHTGVmaA?oc=5","date":"2017-07-11","type":"pipeline","source":"BioSpace","summary":"CURE Pharma & Therapix Signs MOU With Israel's Assuta Medical Center To Develop First-In-Class Therapeutic Products In Fields Of Personalized Medicine & Cannabinoids - BioSpace","headline":"CURE Pharma & Therapix Signs MOU With Israel's Assuta Medical Center To Develop First-In-Class Therapeutic Products In F","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}